Company intelligence / Profile preview

OmniAb

Emeryville, California, United Statesomniab.com ↗
Ownership
Public · OABI
Employees
~114
Development stage
Commercial
01

Overview

OmniAb provides industry-leading transgenic animal-based platforms and AI-powered technologies to enable pharmaceutical partners to discover fully human antibodies and other next-generation biologics. Its technologies are widely adopted by over 90 biopharma companies globally. Clinical results pertain to partner programs using the platform rather than direct development by OmniAb itself.

Therapeutic areas
OncologyImmunologyNeurologyInfectious Diseases
Modalities
Monoclonal antibodyBispecific monoclonal antibodyAntibody-drug conjugateCAR-T cell therapyTargeted radiopharmaceuticalSingle domain antibody (nanobody)
Industry
Drug Discovery Services
02

Partnerships

Over 90 biopharmaceutical companies and research institutions worldwide license or collaborate with OmniAb for their drug discovery effortsPartnership with mAbsolve Ltd. for Fc-silencing STR technology integration into antibodies generated via the platformExtensive network of CROs experienced in characterization/bioinformatics/cell line development/GMP manufacturing using its technologies
03

Financials

Market cap
$704.5M
Total revenue
$18.7M
Enterprise value
$658.4M

Beyond the preview

Go deeper on OmniAb.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on OmniAb.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call